Abstract
The quality of a TMA experiment can only be as good as the worst step in the entire process. Making and analyzing of tissue microarrays (TMAs) is a complex process involving tissue sample acquisition and preparation, expert histological diagnosis, long-term collection of clinical data, development of suitable laboratory protocols, the microscopic analysis, and the statistical analysis of the experiment. The quality of all these factors equally influences the outcome of TMA studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schlomm, T., Nakel, E., Lubke, A., Buness, A., Chun, F. K., Steuber, T., Graefen, M., Simon, R., Sauter, G., Poustka, A., Huland, H., Erbersdobler, A., Sultmann, H., Hellwinkel, O. J. (2007) Marked gene transcript level alterations occur early during radical prostatectomy. Eur Urol; 53(2):333–44.
Fox, C. H., Johnson, F. B., Whiting, J., Roller, P. P. (1985) Formaldehyde fixation. J Histochem Cytochem; 8:845–53.
Al-Kuraya, K., Schraml, P., Torhorst, J., Tapia, C., Zaharieva, B., Novotny, H., Spichtin, H., Maurer, R., Mirlacher, M., Kochli, O., Zuber, M., Dieterich, H., Mross, F., Wilber, K., Simon, R., Sauter, G. (2004) Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res; 23:8534–40.
Tapia, C., Schraml, P., Simon, R., Al-Kuraya, K. S., Maurer, R., Mirlacher, M., Novotny, H., Spichtin, H., Mihatsch, M. J., Sauter, G. (2004) HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies. Int J Oncol; 6:1551–7.
Torhorst, J., Bucher, C., Kononen, J., Haas, P., Zuber, M., Kochli, O. R., Mross, F., Dieterich, H., Moch, H., Mihatsch, M., Kallioniemi, O. P., Sauter, G. (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol; 6:2249–56.
Ruiz, C., Seibt, S., Al Kuraya, K., Siraj, A. K., Mirlacher, M., Schraml, P., Maurer, R., Spichtin, H., Torhorst, J., Popovska, S., Simon, R., Sauter, G. (2006) Tissue microarrays for comparing molecular features with proliferation activity in breast cancer. Int J Cancer; 9:2190–4.
Al-Kuraya, K., Schraml, P., Sheikh, S., Amr, S., Torhorst, J., Tapia, C., Novotny, H., Spichtin, H., Maurer, R., Mirlacher, M., Simon, R., Sauter, G. (2005) Predominance of high-grade pathway in breast cancer development of Middle East women. Mod Pathol; 7:891–7.
FDA (1997) U.S. Food and Drug Administration (FDA). In vitro diagnostic devices: guidance for the preparation of 510(k) submissions – Appendix K – points to consider for review of calibration and quality control labeling for in vitro diagnostic devices. 2/1/96; 1–50.
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., Stein, H. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol; 4:1710–5.
Tosoni, I., Wagner, U., Sauter, G., Egloff, M., Knonagel, H., Alund, G., Bannwart, F., Mihatsch, M. J., Gasser, T. C., Maurer, R. (2000) Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int; 1:48–53.
Wrba, F., Reiner, A., Ritzinger, E., Holzner, J. H., Reiner, G. (1988) Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study. Pathol Res Pract; 1:25–9.
Bhargava, R., Gerald, W. L., Li, A. R., Pan, Q., Lal, P., Ladanyi, M., Chen, B. (2005) EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol; 8:1027–33.
Chakravarti, A., Winter, K., Wu, C. L., Kaufman, D., Hammond, E., Parliament, M., Tester, W., Hagan, M., Grignon, D., Heney, N., Pollack, A., Sandler, H., Shipley, W. (2005) Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys; 2:309–17.
Ding, Y., Wang, G., Ling, M. T., Wong, Y. C., Li, X., Na, Y., Zhang, X., Chua, C. W., Wang, X., Xin, D. (2006) Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion. Int J Oncol; 4:847–54.
Lassus, H., Sihto, H., Leminen, A., Joensuu, H., Isola, J., Nupponen, N., Butzow, R. (2006) Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma. J Mol Med; 8:671–81.
Stadlmann, S., Gueth, U., Reiser, U., Diener, P.-A., Zeimet, A. G., Wight, E., Mirlacher, M., Sauter, G., Mihatsch, M. J., Singer, G. (2006) Epithelial growth factor receptor status in primary and recurrent ovarian cancer. Mod Pathol; 4:607–10.
Doger, F. K., Meteoglu, I., Tuncyurek, P., Okyay, P., Cevikel, H. (2006) Does the EGFR and VEGF expression predict the prognosis in colon cancer? Eur Surg Res; 6:540–4.
Rohit, B., Beiyun, C., David, S. K., Leonard, B. S., Cyrus, H., Laura, H. T., William, G., Julie, T.-F., Philip, B. P., Jing, Q., Jinru, S. (2006) Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa. Cancer; 8:1857–62.
Jacobs, T. W., Prioleau, J. E., Stillman, I. E., Schnitt, S. J. (1996) Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst; 15:1054–9.
Manne, U., Myers, R. B., Srivastava, S., Grizzle, W. E. (1997) Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst; 8:585–6.
Bertheau, P., Cazals-Hatem, D., Meignin, V., de Roquancourt, A., Verola, O., Lesourd, A., Sene, C., Brocheriou, C., Janin, A. (1998) Variability of immunohistochemical reactivity on stored paraffin slides. J Clin Pathol; 5:370–4.
Mirlacher, M., Kasper, M., Storz, M., Knecht, Y., Durmuller, U., Simon, R., Mihatsch, M. J., Sauter, G. (2004) Influence of slide aging on results of translational research studies using immunohistochemistry. Mod Pathol; 11:1414–20.
Schlomm, T., Iwers, L., Kirstein, P., Jessen, B., Kollermann, J., Minner, S., Passow-Drolet, A., Mirlacher, M., Milde-Langosch, K., Graefen, M., Haese, A., Steuber, T., Simon, R., Huland, H., Sauter, G., Erbersdobler, A. (2008) Clinical significance of p53 alterations in surgically treated prostate cancers. Mod Pathol; 21(11):1371–8.
Darby, I. A., Bisucci, T., Desmouliere, A., Hewitson, T. D. (2006) In situ hybridization using cRNA probes: isotopic and nonisotopic detection methods. Methods Mol Biol; 326:17–31.
Barlund, M., Forozan, F., Kononen, J., Bubendorf, L., Chen, Y., Bittner, M. L., Torhorst, J., Haas, P., Bucher, C., Sauter, G., Kallioniemi, O. P., Kallioniemi, A. (2000) Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst; 15:1252–9.
Hanley, K. Z., Siddiqui, M. T., Lawson, D., Cohen, C., Nassar, A. (2009) Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis. Diagn Cytopathol; 4:251–7.
Moeder, C. B., Giltnane, J. M., Moulis, S. P., Rimm, D. L. (2009) Quantitative, fluorescence-based in-situ assessment of protein expression. Methods Mol Biol; 520:163–75.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Tennstedt, P., Sauter, G. (2010). Quality Aspects of TMA Analysis. In: Simon, R. (eds) Tissue Microarrays. Methods in Molecular Biology, vol 664. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-806-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-60761-806-5_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-805-8
Online ISBN: 978-1-60761-806-5
eBook Packages: Springer Protocols